These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 27764811)
1. Altered RECQL5 expression in urothelial bladder carcinoma increases cellular proliferation and makes RECQL5 helicase activity a novel target for chemotherapy. Patterson K; Arya L; Bottomley S; Morgan S; Cox A; Catto J; Bryant HE Oncotarget; 2016 Nov; 7(46):76140-76150. PubMed ID: 27764811 [TBL] [Abstract][Full Text] [Related]
2. Decreased RECQL5 correlated with disease progression of osteosarcoma. Wu J; Zhi L; Dai X; Cai Q; Ma W Biochem Biophys Res Commun; 2015 Nov; 467(4):617-22. PubMed ID: 26499077 [TBL] [Abstract][Full Text] [Related]
3. RECQL5/Recql5 helicase regulates homologous recombination and suppresses tumor formation via disruption of Rad51 presynaptic filaments. Hu Y; Raynard S; Sehorn MG; Lu X; Bussen W; Zheng L; Stark JM; Barnes EL; Chi P; Janscak P; Jasin M; Vogel H; Sung P; Luo G Genes Dev; 2007 Dec; 21(23):3073-84. PubMed ID: 18003859 [TBL] [Abstract][Full Text] [Related]
4. Human RECQL5: guarding the crossroads of DNA replication and transcription and providing backup capability. Popuri V; Tadokoro T; Croteau DL; Bohr VA Crit Rev Biochem Mol Biol; 2013; 48(3):289-99. PubMed ID: 23627586 [TBL] [Abstract][Full Text] [Related]
5. Human RECQ Helicase Pathogenic Variants, Population Variation and "Missing" Diseases. Fu W; Ligabue A; Rogers KJ; Akey JM; Monnat RJ Hum Mutat; 2017 Feb; 38(2):193-203. PubMed ID: 27859906 [TBL] [Abstract][Full Text] [Related]
6. DNMT1: an emerging target in the treatment of invasive urinary bladder cancer. Dhawan D; Ramos-Vara JA; Hahn NM; Waddell J; Olbricht GR; Zheng R; Stewart JC; Knapp DW Urol Oncol; 2013 Nov; 31(8):1761-9. PubMed ID: 22609058 [TBL] [Abstract][Full Text] [Related]
7. Inducing cell proliferation inhibition and apoptosis via silencing Dicer, Drosha, and Exportin 5 in urothelial carcinoma of the bladder. Han Y; Liu Y; Gui Y; Cai Z J Surg Oncol; 2013 Feb; 107(2):201-5. PubMed ID: 22766726 [TBL] [Abstract][Full Text] [Related]
8. RECQL4 in genomic instability and aging. Croteau DL; Singh DK; Hoh Ferrarelli L; Lu H; Bohr VA Trends Genet; 2012 Dec; 28(12):624-31. PubMed ID: 22940096 [TBL] [Abstract][Full Text] [Related]
9. Targeting RECQL5 Functions, by a Small Molecule, Selectively Kills Breast Cancer Chakraborty S; Dutta K; Gupta P; Das A; Das A; Ghosh SK; Patro BS J Med Chem; 2021 Feb; 64(3):1524-1544. PubMed ID: 33529023 [TBL] [Abstract][Full Text] [Related]
10. RECQL5 plays an essential role in maintaining genome stability and viability of triple-negative breast cancer cells. Peng J; Tang L; Cai M; Chen H; Wong J; Zhang P Cancer Med; 2019 Aug; 8(10):4743-4752. PubMed ID: 31231988 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of caldesmon is associated with tumor progression in patients with primary non-muscle-invasive bladder cancer. Lee MS; Lee J; Kim JH; Kim WT; Kim WJ; Ahn H; Park J Oncotarget; 2015 Nov; 6(37):40370-84. PubMed ID: 26430961 [TBL] [Abstract][Full Text] [Related]
12. Insights into the RecQ helicase mechanism revealed by the structure of the helicase domain of human RECQL5. Newman JA; Aitkenhead H; Savitsky P; Gileadi O Nucleic Acids Res; 2017 Apr; 45(7):4231-4243. PubMed ID: 28100692 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of thymosin β4 in the regulation of epithelial-mesenchymal transformation in urothelial carcinoma. Wang ZY; Zeng FQ; Zhu ZH; Jiang GS; Lv L; Wan F; Dong R; Xiao XY; Xing SA Urol Oncol; 2012; 30(2):167-76. PubMed ID: 20864366 [TBL] [Abstract][Full Text] [Related]
14. Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage. Caprodossi S; Lucciarini R; Amantini C; Nabissi M; Canesin G; Ballarini P; Di Spilimbergo A; Cardarelli MA; Servi L; Mammana G; Santoni G Eur Urol; 2008 Sep; 54(3):612-20. PubMed ID: 17977643 [TBL] [Abstract][Full Text] [Related]
15. A Blm-Recql5 partnership in replication stress response. Lu X; Lou H; Luo G J Mol Cell Biol; 2011 Feb; 3(1):31-8. PubMed ID: 21278449 [TBL] [Abstract][Full Text] [Related]
16. Direct inhibition of RNA polymerase II transcription by RECQL5. Aygün O; Xu X; Liu Y; Takahashi H; Kong SE; Conaway RC; Conaway JW; Svejstrup JQ J Biol Chem; 2009 Aug; 284(35):23197-203. PubMed ID: 19570979 [TBL] [Abstract][Full Text] [Related]
17. Notch3 overexpression enhances progression and chemoresistance of urothelial carcinoma. Zhang H; Liu L; Liu C; Pan J; Lu G; Zhou Z; Chen Z; Qian C Oncotarget; 2017 May; 8(21):34362-34373. PubMed ID: 28416766 [TBL] [Abstract][Full Text] [Related]
18. Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion. Garg M; Kanojia D; Seth A; Kumar R; Gupta A; Surolia A; Suri A Eur J Cancer; 2010 Jan; 46(1):207-15. PubMed ID: 19914824 [TBL] [Abstract][Full Text] [Related]
19. Mining the role of RECQL5 in gastric cancer and seeking potential regulatory network by bioinformatics analysis. Lin Y; Chen H; Wang X; Xiang J; Wang H; Peng J Exp Mol Pathol; 2020 Aug; 115():104477. PubMed ID: 32497619 [TBL] [Abstract][Full Text] [Related]
20. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder. Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]